Amgen was looking into buying more small-sized but profitable firms after its successful bid with Onyx Pharmaceuticals.
Tags: Amgen Inc
Valeant partners with AstraZeneca for psoriasis drug
Valeant Pharmaceuticals, Inc. of Canada has partnered with AstraZeneca for the selling rights of psoriasis drug brodalumab. Amgen Inc. ended its partnership with AstraZeneca due to its worries over the drug's side effects.
Amgen's new leukemia drug to carry $178,000 price tag
Amgen Inc on Wednesday said its new type of treatment for a deadly form of leukemia would cost about $178,000 when it becomes available on Thursday, which would make it one of the world's most expensive cancer drugs.
Pfizer beats sales and profit forecasts, mum on future deals
Pfizer Inc (PFE.N) reported stronger-than-expected quarterly results, helped by growing sales of its cancer drugs and demand for its medicines in emerging markets, but did not signal any acquisition plans following its recent failed efforts to buy rival British drugmaker AstraZeneca Plc (AZN.L).
Despite Third Point, low expectations for Amgen breakup
Amgen Inc (AMGN.O), one of the world's largest biotechnology companies, will unveil next week its first strategy update since early 2013, but few expect a major shift like the split-up recently proposed by Daniel Loeb's Third Point hedge fund.
Latest News
Amgen Inc. might announced the agreement to acquire Onyx Pharmaceuticals Inc. for USD 125 per share piece as soon as Monday.
1
